The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Open accessAbstract
Assessment of Alzheimer's disease (AD)-related neurofibrillary pathology requires a procedure that permits a sufficient differentiation between initial, intermediate, and late stages. The gradual deposition of a hyperphosphorylated tau protein within select neuronal types in specific nuclei or areas is central to the disease process. The staging of AD-related neurofibrillary pathology originally described in 1991 was performed on unconventionally thick sections (100 mum) using a modern silver technique and reflected the progress of the disease process based chiefly on the topographic expansion of the lesions. To better meet the demands of routine laboratories this procedure is revised here by adapting tissue selection and processing to the needs of paraffin-embedded sections (5-15 mum) and by introducing a robust immunoreaction (AT8) for hyperphosphorylated tau protein that can be processed on an automated basis. It is anticipated that this revised methodological protocol will enable a more uniform application of the staging procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulation of Aβ plaques and NFTs follows distinct regional progressions across brain regions as AD advances.”
From National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach (2012) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with the stereotypical hierarchical accumulation of NFTs along neural networks20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They were categorized into the stage C of amyloid deposition and the stage VI of neurofibrillary degeneration, following the Braak's staging (13).”
From Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease (2017) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“by definition, the primary visual cortex (V1 region) bears NFTs only in Braak NFT stage VI20,21”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“we rank ordered the five brain regions based on their known vulnerability to neurofibrillary degeneration20,21 (that is, EC > ITG > PFC > V2 > V1)”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“the distinguishing feature between Braak NFT stages V and VI is not just the presence of NFTs in the primary visual (V1), motor and sensory cortical areas, but more severe neurofibrillary degeneration21 and atrophy throughout the cortical mantle51”
From Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease (2024) · cites this paper as [21]
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [2]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Self-citation
Research works printed but not linked: 7
- Alzheimer A (1906) Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurolog Centralbl 23:1129–1136
- Bielschowsky M (1902) Die Silberimprägnation der Axenzylinder. Neurol Centralb 13:579–584
- Bielschowsky M (1903) Die Silberimprägnation der Neurofibrillen. Neurol Centralb 21:997–1006
- Bielschowsky M (1904) Die Silberimprägnation der Neurofibrillen. Einige Bemerkungen zu der von mir angegebenen Methode und den von ihr gelieferten Bildern. J Psychol Neurol 3:169–189
- Bielschowsky M (1905) Die Darstellung der Axenzylinder peripherischer Nervenfasern und der Axenzylinder zentraler markhaltiger Nervenfasern. Ein Nachtrag zu der von mir angegebenen Imprägnationsmethode der Neurofibrillen. J Psychol Neurol 4:228–231
- Bielschowsky M (1909) Eine Modifikation meines Silberimprägnations-verfahrens zur Darstellung der Neurofibrillen. J Psychol Neurol 12:135–137
- Duyckaerts C, He Y, Seilhean D, Delaère P, Piette F, Braak H, Hauw JJ (1994) Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals. Neurobiol Aging 15(Suppl 1):140–141
Cited by
Sorted by citations
Items 801–900 of 1,028
A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology
Marttinen, M., Paananen, J., Neme, A., Mitra, V., Takalo, M., Natunen, T., Paldanius, K. M. A., Mäkinen, P. M., Bremang, M., Kurki, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.009 · Cited by 55
Tau phosphorylation in a mouse model of temporal lobe epilepsy.
Alves, M., Kenny, A., de Leo, G., Beamer, E. H., & Engel, T. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00308 · Cited by 54
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Dominguez‐Meijide, A., Vasili, E., König, A., Cima‐Omori, M., de Opakua, A. I., Leonov, A., Ryazanov, S., Zweckstetter, M., Griesinger, C., & Outeiro, T. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-69744-y · Cited by 52
Multiview Feature Learning With Multiatlas-Based Functional Connectivity Networks for MCI Diagnosis
Zhang, Y., Zhang, H., Adeli, E., Chen, X., Liu, M., & Shen, D. G. (2020) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2020.3016953 · Cited by 54
Subtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns
Kwak, K., Giovanello, K. S., Bozoki, A., Styner, M., & Dayan, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100467 · Cited by 47
Astillero‐Lopez, V., Villar‐Conde, S., González-Rodríguez, M., Flores‐Cuadrado, A., Úbeda‐Bañón, I., Saiz‐Sánchez, D., & Martínez-Marcos, A. (2024) · Brain Pathology · doi:10.1111/bpa.13235 · Cited by 54
Martiskainen, H., Helisalmi, S., Viswanathan, J., Kurki, M., Hall, A., Herukka, S., Sarajärvi, T., Natunen, T., Kurkinen, K. M. A., Huovinen, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140777 · Cited by 56
Hypoxia and GABA shunt activation in the pathogenesis of Alzheimer's disease
Salminen, A., Jouhten, P., Sarajärvi, T., Haapasalo, A., & Hiltunen, M. O. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.005 · Cited by 56
Garcia‐Esparcia, P., López‐González, I., Grau‐Rivera, O., Garrido, M. G., Koneti, A., Llorens, F., Zafar, S., Carmona, M., del Río, J. A., Zerr, I., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00089 · Cited by 54
Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
Chang, H.-Y., Sang, T., & Chiang, A. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0457-x · Cited by 56
Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders
Patterson, L., Rushton, S., Attems, J., Thomas, A. J., & Morris, C. M. (2018) · Brain Pathology · doi:10.1111/bpa.12697 · Cited by 53
The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease
Sun, J., Martin, J. M., Vanderpoel, V., & Sumbria, R. K. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08524-y · Cited by 56
Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.
Garcia‐Esparcia, P., Sideris-Lampretsas, G., Hernández‐Ortega, K., Grau‐Rivera, O., Sklaviadis, T., Gelpí, E., & Ferrer, I. (2017) · Europe PMC (PubMed Central) · Cited by 53
Patel, K. P., Wymer, D. T., Bhatia, V. K., Duara, R., & Rajadhyaksha, C. D. (2020) · Radiographics · doi:10.1148/rg.2020190070 · Cited by 54
Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration
Cervera‐Carles, L., Dols‐Icardo, O., Molina‐Porcel, L., Alcolea, D. A., González, A. C., Muñoz, L., & Clarimón, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.017 · Cited by 53
Mathur, R., Ince, P. G., Minett, T., Garwood, C. J., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., Wharton, S. B., & on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · PLOS ONE · doi:10.1371/journal.pone.0118463 · Cited by 52
Progressive signaling changes in the olfactory nerve of patients with Alzheimer's disease
Bathini, P., Mottas, A., Jaquet, M., Brai, E., & Alberi, L. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.006 · Cited by 52
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy
Owasil, R., O’Neill, R., Keable, A., Nimmo, J., MacGregor Sharp, M., Kelly, L., Saito, S., Simpson, J. E., Weller, R. O., Smith, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041225 · Cited by 48
Leuzy, A., Rakêt, L. L., Villemagne, V. L., Klein, G., Tonietto, M., Olafson, E., Baker, S. L., Saad, Z. S., Bullich, S., Lopresti, B. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13908 · Cited by 53
Satoh, J.-I., Yamamoto, Y., Asahina, N., Kitano, S., & Kino, Y. (2014) · Disease Markers · doi:10.1155/2014/123165 · Cited by 53
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
Colom‐Cadena, M., Gelpí, E., Martı́, M. J., Charif, S., Dols‐Icardo, O., Blesa, R., Clarimón, J., & Lleó, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.015 · Cited by 53
Asymmetry of neurodegenerative disease-related pathologies: a cautionary note
Stefanits, H., Budka, H., & Kovács, G. G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0936-6 · Cited by 54
Heggland, I., Storkaas, I. S., Soligard, H., Kobro‐Flatmoen, A., & Witter, M. P. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12876 · Cited by 53
Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., Martin, J., & Deyn, P. P. D. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0090-1 · Cited by 52
Keogh, M. J., Wei, W., Wilson, I., Coxhead, J., Ryan, S., Rollinson, S. J., Griffin, H. R., Kurzawa‐Akanbi, M., Santibanez‐Koref, M., Talbot, K., et al. (2016) · Genome Research · doi:10.1101/gr.210609.116 · Cited by 51
Meadowcroft, M. D., Connor, J. R., & Yang, Q. X. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00255 · Cited by 51
Appleton, J., Finn, Q., Zanotti-Fregonara, P., Yu, M., Faridar, A., Nakawah, M. O., Zarate, C., Carrillo, M. C., Dickerson, B. C., Rabinovici, G. D., et al. (2025) · Brain · doi:10.1093/brain/awae234 · Cited by 58
Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors
Allan, L. M., Rowan, E. N., Thomas, A. J., Polvikoski, T. M., O'Brien, J. T., & Kalaria, R. N. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.128355 · Cited by 51
Sex differences for phenotype in pathologically defined dementia with Lewy bodies
Bayram, E., Coughlin, D. G., Banks, S. J., & Litvan, I. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325668 · Cited by 52
Astillero‐Lopez, V., González-Rodríguez, M., Villar‐Conde, S., Flores‐Cuadrado, A., Martı́nez-Marcos, A., Úbeda‐Bañón, I., & Saiz‐Sánchez, D. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12580 · Cited by 53
Evolutional Aspects of Alzheimer's Disease Pathogenesis
Braak, H., & Tredici, K. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129029 · Cited by 54
Self-citationCarrano, A., Snkhchyan, H., Kooij, G., van der Pol, S., van Horssen, J., Veerhuis, R., Hoozemans, J., Rozemuller, A., & de Vries, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.015 · Cited by 51
Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment
LeBlanc, A. C., Ramcharitar, J., Afonso, V. M., Hamel, É., Bennett, D. A., Pakavathkumar, P., & Albrecht, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.194 · Cited by 51
Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status
Monsell, S. E., Besser, L. M., Heller, K., Checkoway, H., Litvan, I., & Kukull, W. A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.001 · Cited by 52
The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease
Jeynes, B., & Provias, J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22527 · Cited by 51
Small, S. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.030 · Cited by 55
Parlapani, E., Schmitt, A., Wirths, O., Bauer, M., Sommer, C., Rueb, U., Skowronek, M. H., Treutlein, J., Petroianu, G. A., Rietschel, M., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802022376 · Cited by 53
TMEM106B expression is reduced in Alzheimer’s disease brains
Satoh, J., Kino, Y., Kawana, N., Yamamoto, Y., Ishida, T., Saito, Y., & Arima, K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt247 · Cited by 51
The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau
Shen, L., Manucat-Tan, N. B., Gao, S.-H., Li, W., Zeng, F., Zhu, C., Wang, J., Bu, X., Liu, Y.-H., Gao, C.-Y., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0071-z · Cited by 50
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
Camacho, J., Moliné, T., Bonaterra‐Pastra, A., y Cajal, S. R., Martínez-Sáez, E. A., & Hernández‐Guillamón, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00187 · Cited by 52
Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease
Kulason, S., Xu, E., Tward, D. J., Bakker, A., Albert, M., Laurent Younes, B., & Miller, M. I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00804 · Cited by 51
The Delayed Neuropathological Consequences of Traumatic Brain Injury in a Community-Based Sample
Postupna, N. O., Rose, S. E., Gibbons, L. E., Coleman, N., Hellstern, L. L., Ritchie, K., Wilson, A. M., Cudaback, E., Li, X., Melief, E. J., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.624696 · Cited by 51
Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia
Schmitt, A., Koschel, J., Zink, M., Bauer, M., Sommer, C., Frank, J., Treutlein, J., Schulze, T. G., Schneider-Axmann, T., Parlapani, E., et al. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0017-1 · Cited by 53
GRN Variant rs5848 Reduces Plasma and Brain Levels of Granulin in Alzheimer's Disease Patients
Kämäläinen, A., Viswanathan, J., Natunen, T., Helisalmi, S., Kauppinen, T., Pikkarainen, M., Pursiheimo, J., Alafuzoff, I. I., Kivipelto, M., Haapasalo, A., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120946 · Cited by 50
Self-citationNellessen, N. D., Rottschy, C., Eickhoff, S. B., Ketteler, S. T., Kuhn, H., Shah, N. J., Schulz, J. B., Reske, M., & Reetz, K. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0744-6 · Cited by 49
Portelius, E., Lashley, T., Westerlund, A., Persson, R., Fox, N. C., Blennow, K., Révész, T., & Zetterberg, H. (2015) · Neurodegenerative Diseases · doi:10.1159/000369465 · Cited by 51
PLD3 is accumulated on neuritic plaques in Alzheimer’s disease brains
Satoh, J., Kino, Y., Yamamoto, Y., Kawana, N., Ishida, T., Saito, Y., & Arima, K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0070-5 · Cited by 50
Luna‐Muñoz, J., Peralta‐Ramirez, J., Chávez-Macías, L., Harrington, C. R., Wischik, C. M., & Mena, R. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0431-x · Cited by 50
Vermeiren, Y., Janssens, J., Aerts, T., Martin, J., Sieben, A., Dam, D. V., & Deyn, P. P. D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160320 · Cited by 51
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58
Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
Libard, S., Cerjan, D., & Alafuzoff, I. I. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1742-1 · Cited by 52
Self-citationBaiardi, S., Abu‐Rumeileh, S., Rossi, M., Zenesini, C., Bartoletti‐Stella, A., Polischi, B., Capellari, S., & Parchi, P. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.697 · Cited by 53
Timmers, T., Ossenkoppele, R., Wolters, E. E., Verfaillie, S. C. J., Visser, D., Golla, S. S. V., Barkhof, F., Scheltens, P., Boellaard, R., van der Flier, W. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0510-3 · Cited by 55
Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition
Risacher, S. L., WuDunn, D., Tallman, E. F., West, J. D., Gao, S., Farlow, M. R., Brosch, J. R., Apostolova, L. G., & Saykin, A. J. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa019 · Cited by 50
Behavioral Abnormalities in Knockout and Humanized Tau Mice
Gonçalves, R. A., Wijesekara, N., Fraser, P. E., & Felice, F. G. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00124 · Cited by 52
Sex specific molecular networks and key drivers of Alzheimer’s disease
Guo, L., Cao, J., Hou, J., Li, Y., Huang, M., Zhu, L., Zhang, L., Lee, Y., Duarte, M. L., Zhou, X., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00624-5 · Cited by 49
Neuropathological correlates of neuropsychiatric symptoms in dementia
Gibson, L. L., Grinberg, L. T., Ffytche, D. H., Leite, R. E. P., Rodriguez, R. D., Ferretti‐Rebustini, R. E. D. L., Pasqualucci, C. A., Nitríni, R., Filho, W. J., Aarsland, D., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12765 · Cited by 51
Barbera, L. L., Nobili, A., Cauzzi, E., Paoletti, I., Federici, M., Saba, L., Giacomet, C., Marino, R., Krashia, P., Melone, M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00580-6 · Cited by 49
Bollack, A., Pemberton, H., Collij, L. E., Markiewicz, P. J., Cash, D. M., Farrar, G., & Barkhof, F. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13158 · Cited by 51
Ultra-High Field 7T MRI: A New Tool for Studying Alzheimer's Disease
Kerchner, G. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0023 · Cited by 49
Calcium phosphatase calcineurin influences tau metabolism
Karch, C. M. M., Jeng, A. T., & Goate, A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.003 · Cited by 51
Shi, J., Stonnington, C. M., Thompson, P. M., Chen, K., Gutman, B. A., Reschke, C., Baxter, L. C., Reiman, E. M., Caselli, R. J., & Wang, Y. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.062 · Cited by 50
Kalimo, H., Lalowski, M. M., Bogdanović, N., Philipson, O., Bird, T. D., Nochlin, D., Schellenberg, G. D., Brundin, R., Olofsson, T., Soliymani, R., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-60 · Cited by 52
Datta, A., Akatsu, H., Heese, K., & Sze, S. K. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.08.017 · Cited by 51
Exome sequencing in dementia with Lewy bodies
Keogh, M. J., Kurzawa‐Akanbi, M., Griffin, H. R., Douroudis, K., Ayers, K. L., Hussein, R. I., Hudson, G., Pyle, A., Cordell, H. J., Attems, J., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.220 · Cited by 50
Maurer, A. P., Johnson, S. A., Hernandez, A. R., Reasor, J. E., Cossio, D. M., Fertal, K. E., Mizell, J. M., Lubke, K. N., Clark, B. J., & Burke, S. N. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00049 · Cited by 49
Hogenboom, R., Kalsbeek, M. J. T., Korpel, N. L., de Goede, P., Koenen, M., Buijs, R. M., Romijn, J. A., Swaab, D. F., Kalsbeek, A., & Yi, C. (2019) · Diabetologia · doi:10.1007/s00125-019-4953-7 · Cited by 49
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification
Hett, K., Ta, V.-T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49970-9 · Cited by 49
Tward, D. J., Brown, T., Kageyama, Y., Patel, J., Hou, Z., Mori, S., Albert, M., Troncoso, J. C., & Miller, M. I. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00052 · Cited by 48
Abnormal tau in amyloid PET negative individuals
Yoon, B., Guo, T., Provost, K., Korman, D., Ward, T. J., Landau, S. M., & Jagust, W. J. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.019 · Cited by 52
Novel Styrylpyridines as Probes for SPECT Imaging of Amyloid Plaques
Qü, W., Kung, M., Hou, C., Benedum, T. E., & Kung, H. F. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070025+ · Cited by 49
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer’s disease
Coughlin, D. G., Ittyerah, R., Peterson, C. S., Phillips, J. S., Miller, S., Rascovsky, K., Weintraub, D. A., Siderowf, A. D., Duda, J. E., Hurtig, H. I., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12659 · Cited by 45
Long, J. M., Coble, D. W., Xiong, C., Schindler, S. E., Perrin, R. J., Gordon, B. A., Benzinger, T. L. S., Grant, E., Fagan, A. M., Harari, O., et al. (2022) · Brain · doi:10.1093/brain/awac250 · Cited by 49
Costoya‐Sánchez, A., Moscoso, A., Silva‐Rodríguez, J., Pontecorvo, M. J., Devous, M. D., Aguiar, P., Schöll, M., Grothe, M. J., Initiative, A. D. N., Weiner, M. W., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.2560 · Cited by 52
Yang, H., Teng, L., Kang, D., Menon, V., Ge, T., Finucane, H. K., Schultz, A. P., Properzi, M. J., Klein, H., Chibnik, L. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43132-2 · Cited by 56
Naude, J., Wang, M., Leon, R., Smith, E. E., & Ismail, Z. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.02.006 · Cited by 49
Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics
Rexach, J. E., Cheng, Y., Chen, L., Polioudakis, D., Lin, L., Mitri, V., Elkins, A., Han, X., Yamakawa, M., Yin, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.019 · Cited by 59
Neuropathologic analysis of Lewy‐related α‐synucleinopathy in olfactory mucosa
Funabe, S., Takao, M., Saito, Y., Hatsuta, H., Sugiyama, M., Ito, S., Kanemaru, K., Sawabe, M., Arai, T., Mochizuki, H., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2012.01329.x · Cited by 50
Terni, B., & Ferrer, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142460 · Cited by 46
Beach, T. G., Thal, D. R., Zanette, M., Smith, A. P. L., & Buckley, C. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150732 · Cited by 48
McAllister, B. B., Lacoursiere, S. G., Sutherland, R. J., & Mohajerani, M. H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.01.026 · Cited by 48
Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology
Scarioni, M., Gami‐Patel, P., Timar, Y. S. S., Seelaar, H., Swieten, J. C. V., Rozemüller, A. J. M., Dols, A., Scarpini, E. A., Galimberti, D., Bank, N. B., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25739 · Cited by 48
Michael, J., Unger, M. S., Poupardin, R., Schernthaner, P., Mrowetz, H., Attems, J., & Aigner, L. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00989-4 · Cited by 47
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.630172 · Cited by 47
Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease
Satoh, J., Kino, Y., Yanaizu, M., Ishida, T., & Saito, Y. (2019) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2019.01049 · Cited by 48
CDT2‐controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease
Huang, F., Wang, M., Liu, R., Wang, J., Schadt, E., Haroutunian, V., Katsel, P., Zhang, B., & Wang, X. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.013 · Cited by 47
Biomarkers of Alzheimer’s disease: Past, present and future clinical use
Georgakas, J. E., Howe, M. D., Thompson, L. I., Riera, N. M., & Riddle, M. C. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100063 · Cited by 52
Walker, J. M., Orr, M. E., Orr, T. C., Thorn, E. L., Christie, T. D., Yokoda, R. T., Vij, M., Ehrenberg, A. J., Marx, G. A., McKenzie, A. T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13484 · Cited by 45
Calderón‐Garcidueñas, L., Stommel, E. W., Torres‐Jardón, R., Hernández-Luna, J., Aiello-Mora, M., González-Maciel, A., Reynoso-Robles, R., Pérez-Guillé, B., Silva-Pereyra, H. G., Tehuacanero-Cuapa, S., et al. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1297467 · Cited by 49
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Alzheimer’s Disease-Related Protein Expression in the Retina of Octodon degus
Du, L. Y., Chang, L., Ardiles, Á. O., Tapia‐Rojas, C., Araya, J., Inestrosa, N. C., Palacios, A. G., & Acosta, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135499 · Cited by 51
Neuropathological features of multiple system atrophy with cognitive impairment
Asi, Y. T., Ling, H., Ahmed, Z., Lees, A. J., Révész, T., & Holton, J. L. (2014) · Movement Disorders · doi:10.1002/mds.25887 · Cited by 47
Elahi, M., Hasan, Z., Motoi, Y., Matsumoto, S., Ishiguro, K., & Hattori, N. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150820 · Cited by 47
Energy and the Alzheimer brain
Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 47
Unger, M. S., Marschallinger, J., Kaindl, J., Klein, B., Johnson, M. A., Khundakar, A. A., Roßner, S., Heneka, M. T., Couillard‐Després, S., Rockenstein, E. M., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.02.017 · Cited by 48
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 49
Circulating extracellular vesicles: friends and foes in neurodegeneration
Calvani, R., Picca, A., Guerra, F., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320972 · Cited by 48
Fujimi, K., Noda, K., Sasaki, K., Wakisaka, Y., Tanizaki, Y., Iida, M., Kiyohara, Y., Kanba, S., & Iwaki, T. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101957 · Cited by 47
Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
Zhang, Y., Li, X., Ren, K., Peng, J., & Luo, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101931 · Cited by 46
Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series
Mayà, G., Iranzo, Á., Gaig, C., Sánchez‐Valle, R., Serradell, M., Molina‐Porcel, L., Santamaría, J., Gelpí, E., & Aldecoa, I. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00402-2 · Cited by 50
Metadata
- Authors
- Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K.
- Affiliations
- Goethe University Frankfurt (DE)
- Kuopio University Hospital (FI)
- Institut für Neuropathologie (DE)
- Corresponding author
- Braak, Heiko
- Venue
- Acta Neuropathologica
- Published
- 2006-08-12
- Volume
- 112
- Issue
- 4
- Pages
- 389-404
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3906709
- OpenAlex
- W2093650784
- Cited by
- 3,172
- References
- 101
- Citations by year
- 2026: 218 · 2025: 259 · 2024: 334 · 2023: 254 · 2022: 251 · 2021: 261 · 2020: 228 · 2019: 205 · 2018: 157 · 2017: 135 · 2016: 140 · 2015: 118 · 2014: 134 · 2013: 95 · 2012: 77
- FWCI
- 34.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2004-503039)
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary pathology, disease staging, AT8 antibody, immunocytochemistry, paraffin sections, silver staining
- MeSH terms
- Alzheimer Disease, Humans, Immunohistochemistry, Amyloid beta-Peptides, Paraffin Embedding, Tissue Fixation, Neurofibrillary Tangles, tau Proteins, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
